Alta Partners Management Company’s Vir Biotechnology VIR Stock Holding History

Alta Partners Management Company’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.2M	Hold	509,917	–	–	4.08%	2
2026 Q1	$4.57M	Hold	509,917	–	–	3.03%	2
2025 Q4	$3.07M	Hold	509,917	–	–	2.97%	2
2025 Q3	$2.91M	Hold	509,917	–	–	4.85%	2
2025 Q2	$2.57M	Buy	509,917 +8,000	+2%	+$42.9K	6.18%	2
2025 Q1	$3.25M	Buy	501,917 +12,432	+3%	+$111K	7.78%	2
2024 Q4	$3.59M	Buy	+489,485	New	+$3.86M	5.67%	2

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Alta Partners Management Company's VIR Position: Q2 2026 in Review

Alta Partners Management Company held its Vir Biotechnology (VIR) position steady in Q2 2026 at 509,917 shares worth $5.2M. The position accounts for 4.08% of the portfolio, ranked #2.

Alta Partners Management Company first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Alta Partners Management Company held 509,917 shares of Vir Biotechnology worth $5.2M as of Q2 2026.
Alta Partners Management Company left its Vir Biotechnology share count unchanged in Q2 2026.
Vir Biotechnology made up 4.08% of Alta Partners Management Company's portfolio in Q2 2026, its #2 holding.
Alta Partners Management Company first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Alta Partners Management Company's 13F filing for Q2 2026, filed 22 Jul 2026.